Cargando…

S16. INDEPENDENT SUPPORT FOR CORTICOPALLIDAL CONTRIBUTIONS TO SCHIZOPHRENIA-RELATED FUNCTIONAL IMPAIRMENT

Abstract not included.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233875/ http://dx.doi.org/10.1093/schbul/sbaa031.082

Ejemplares similares

S142. NOVEL CONCEPTS OF SOCIAL IMPAIRMENTS IN SCHIZOPHRENIA
por: Bitsch, Florian, et al.
Publicado: (2020)

S68. DIFFERENTIAL PATTERN OF SOCIAL COGNITION IMPAIRMENT BETWEEN RURAL AND URBAN DWELLING PATIENTS OF SCHIZOPHRENIA AND ITS FUNCTIONAL CORRELATES
por: Ibrahim, Ferose, et al.
Publicado: (2020)

S54. THE RELATION OF FORMAL THOUGHT DISORDER WITH COGNITIVE FUNCTIONS, GLOBAL AND SOCIAL FUNCTIONING AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Mutlu, Emre, et al.
Publicado: (2020)

S153. IMPAIRED THETA PHASE-COUPLING BETWEEN HIPPOCAMPUS AND MEDIAL PREFRONTAL CORTEX IN SCHIZOPHRENIA
por: Adams, Rick, et al.
Publicado: (2020)

S185. IMPACT OF GENETIC LIABILITY TO SCHIZOPHRENIA ON IMPAIRED MIGRATION OF AUTOLOGOUS INDUCED NEURAL STEM CELLS
por: Lee, Junhee, et al.
Publicado: (2020)

S66. USING UNITIZATION TO CIRCUMVENT RELATIONAL MEMORY DEFICITS IN SCHIZOPHRENIA
por: de Sousa, Ana Elisa Farias, et al.
Publicado: (2020)

S49. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
por: Hoşgelen, Emine Ilgın, et al.
Publicado: (2020)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

S234. DEPRESSION AND SEXUAL FUNCTIONING: TWO NEGLECTED AND PREVALENT DOMAINS IN PEOPLE WITH SCHIZOPHRENIA
por: Lapa, Clara, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

S105. DIGITAL BIOMARKERS FOR THE ASSESSMENT OF COGNITIVE, BEHAVIORAL AND FUNCTIONAL OUTCOMES IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

S55. PRAGMATIC INFERENCES IN SCHIZOPHRENIA: RELATIONSHIP WITH SYMPTOM DOMAINS, THEORY OF MIND AND NEUROCOGNITIVE FUNCTIONS
por: Yalincetin, Berna, et al.
Publicado: (2020)

S146. ASSOCIATION OF IMPAIRED MODEL-FREE DECISION-MAKING WITH ABERRANT STRIATAL DOPAMINE, BRAIN ACTIVATION, AND COGNITIVE DIFFICULTIES IN PATIENTS WITH SCHIZOPHRENIA DURING PSYCHOTIC REMISSION
por: Brandl, Felix, et al.
Publicado: (2020)

S156. PUBLIC ATTENTION TO CRIME OF SCHIZOPHRENIA AND ITS CORRELATION WITH USE OF MENTAL HEALTH SERVICES IN PATIENTS WITH SCHIZOPHRENIA
por: Park, Hyunwoo, et al.
Publicado: (2020)

S91. OPIOID USE AND SCHIZOPHRENIA: AN UPDATE
Publicado: (2020)

S152. DIAGNOSTIC CLASSIFICATION OF SCHIZOPHRENIA USING 3D CONVOLUTIONAL NEURAL NETWORK WITH RESTING-STATE FUNCTIONAL MRI
por: Kim, Harin, et al.
Publicado: (2020)

S198. SELF-DISTURBANCES AND THEIR NEURAL SIGNATURES IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2020)

S155. DIETARY PATTERNS AND OBESITY IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Amirah Abdul Rashid, Nur, et al.
Publicado: (2020)

S158. URBANICITY INDEX AND CORTICAL GYRIFICATION IN SCHIZOPHRENIA
por: Korann, Vittal, et al.
Publicado: (2020)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020)

S180. THE SELECTIVE GPR139 AGONIST TAK-041 REVERSES ANHEDONIA AND SOCIAL INTERACTION DEFICITS IN RODENT MODELS RELATED TO NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Schiffer, Hans, et al.
Publicado: (2020)

S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Haining, Kate, et al.
Publicado: (2020)

S237. MODERATORS AND RELATIONSHIPS OF COGNITION AND SUBJECTIVE QUALITY OF LIFE IN SCHIZOPHRENIA
por: Tan, Eric, et al.
Publicado: (2020)

S223. DETERMINANTS OF SUSTAINED UNEMPLOYMENT IN FORMERLY EMPLOYED SCHIZOPHRENIA PATIENTS
por: Fundora-Trujillo, Cynthia, et al.
Publicado: (2020)

S233. INTERNALIZED STIGMA IN PATIENTS WITH SCHIZOPHRENIA - A TRANSCULTURAL STUDY
Publicado: (2020)

S46. IMPAIRED ERROR-PROCESSING IN PATIENTS WITH FIRST-EPISODE PSYCHOSIS: AN EVENT-RELATED POTENTIAL STUDY
por: Park, Jihye, et al.
Publicado: (2020)

S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA?
por: Breier, Alan, et al.
Publicado: (2020)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

S149. CHANGES IN FRONTO-PARIETAL CONNECTIVITY IN SCHIZOPHRENIA: TMS AND FNIRS STUDY
por: Ćurčić-Blake, Branislava, et al.
Publicado: (2020)

S168. THE ASSOCIATION BETWEEN MMP-9 AND CHOROID PLEXUS VOLUME IN SCHIZOPHRENIA
por: Seethaler, Magdalena, et al.
Publicado: (2020)

S97. IS EARLY DEBUT OF SUBSTANCE USE ASSOCIATED WITH VIOLENT OFFENDING IN SCHIZOPHRENIA?
por: Breivik Storvestre, Guttorm, et al.
Publicado: (2020)

S116. PRAGMATIC COMPREHENSION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Parola, Alberto, et al.
Publicado: (2020)

S190. WHEN WORDS AREN’T ENOUGH: DANCE/MOVEMENT THERAPY AND SCHIZOPHRENIA
por: Biondo, Jacelyn, et al.
Publicado: (2020)

S191. A SCOPING REVIEW AND PHENOMENOLOGICAL EVALUATION OF METACOGNITIVE TRAINING FOR SCHIZOPHRENIA
por: Brar, Pavan, et al.
Publicado: (2020)

S78. TIME PREDICTION AND SENSE OF SELF: LACK OF FLEXIBILITY IN PATIENTS WITH SCHIZOPHRENIA
por: Giersch, Anne, et al.
Publicado: (2020)

S50. COGNITION AND EMOTION REGULATION IN SCHIZOPHRENIA PATIENTS WITH A HISTORY OF AGGRESSION
por: Ahmed, Anthony, et al.
Publicado: (2020)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

S184. IN SILICO PREDICTION OF T-CELL-MEDIATED MOLECULAR MIMICRY IN TOXOPLASMOSIS AND SCHIZOPHRENIA
por: Thylur, David, et al.
Publicado: (2020)

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL
por: Vanover, Kimberly, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_67hkmkmbumqouvqe3vo34fmu41